π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This is an open label, randomized, multicenter study evaluating the activit...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2019-09-20
Trial ID
NCT03781063
Treatments Being Tested
The objective of the study is to demonstrate the effects that lasofoxifene ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2004-09
Trial ID
NCT00674453
Treatments Being Tested
The purpose of the study is to determine the safety and effectiveness of 2 ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2001-11
Trial ID
NCT00141323
Treatments Being Tested
Study Objectives: Primary: β’ To assess the safety, tolerability, and syst...
Status
Recruiting
Location
Nucleus Network
Start Date
2026-06-01
Trial ID
NCT06197568
Treatments Being Tested
The goal of this clinical trial is to assess the efficacy, safety and toler...
Status
Recruiting
Location
Mayo Clinic - Scottsdale
Start Date
2023-10-31
Trial ID
NCT05696626
Treatments Being Tested
The purpose of this study is to further advance the ability to practice per...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2010-03-01
Trial ID
NCT01042379
Treatments Being Tested
This is an open-label, multicenter, single-arm safety study evaluating the ...
Status
Completed
Location
University of Alabama at Birmingham (UAB) - Comprehensive Cancer Center
Start Date
2020-09-29
Trial ID
NCT04432454
Treatments Being Tested
To establish the optimal dose of lasofoxifene that is fully effective in in...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2004-06
Trial ID
NCT00143273
Treatments Being Tested
To compare the effects of 2 years of lasofoxifene treatment with 2 years of...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2003-05
Trial ID
NCT00163137
Treatments Being Tested